The association of HLA-DRB1 alleles and MBL2 gene variant in pediatric acute lymphoblastic leukemia patients.

[1]  G. Bahat,et al.  Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection , 2021, Infection, Genetics and Evolution.

[2]  M. Watanabe,et al.  Acute lymphoid leukemia etiopathogenesis , 2021, Molecular Biology Reports.

[3]  M. Fariñas,et al.  Low pre-transplant levels of mannose-binding lectin are associated with viral infections and mortality after haematopoietic allogeneic stem cell transplantation , 2019, BMC Immunology.

[4]  A. Mangano,et al.  Post‐infectious bronchiolitis obliterans and mannose‐binding lectin insufficiency in Argentinean children , 2015, Respirology.

[5]  U. Pötschger,et al.  Mannan-binding lectin deficiency attenuates acute GvHD in pediatric hematopoietic stem cell transplantation , 2015, Bone Marrow Transplantation.

[6]  F. Ozkinay,et al.  Gene polymorphisms and febrile neutropenia in acute leukemia--no association with IL-4, CCR-5, IL-1RA, but the MBL-2, ACE, and TLR-4 are associated with the disease in Turkish patients: a preliminary study. , 2014, Genetic testing and molecular biomarkers.

[7]  J. Wiemels.  Perspectives on the causes of childhood leukemia. , 2012, Chemico-biological interactions.

[8]  G. Gedikoğlu,et al.  The Frequency of HLA Class I and II Alleles in Turkish Childhood Acute Leukaemia Patients , 2010, The Journal of international medical research.

[9]  J. Bernhagen,et al.  Macrophage migration inhibitory factor (MIF): a promising biomarker. , 2010, Drug news & perspectives.

[10]  A. Simon,et al.  Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose‐binding lectin‐associated serine protease‐2 (MASP‐2) , 2009, Pediatric blood & cancer.

[11]  A. Chokkalingam,et al.  The human major histocompatibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry. , 2009, Blood cells, molecules & diseases.

[12]  E. Haan,et al.  Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. , 2008, American journal of obstetrics and gynecology.

[13]  Leslie L Robison,et al.  Acute lymphoblastic leukaemia , 2018, Radiopaedia.org.

[14]  F. Sabaghi,et al.  Frequencies of HLA-DRB1 in Iranian normal population and in patients with acute lymphoblastic leukemia. , 2008, Archives of medical research.

[15]  S. Thiel,et al.  New perspectives on mannan-binding lectin-mediated complement activation. , 2007, Immunobiology.

[16]  A. Holmes,et al.  Risk Factors for Acute Leukemia in Children: A Review , 2006, Environmental health perspectives.

[17]  E. Montserrat,et al.  Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. , 2006, Experimental hematology.

[18]  H. Caron,et al.  The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. , 2006, European journal of cancer.

[19]  A. Dickinson,et al.  Beyond the HLA typing age: genetic polymorphisms predicting transplant outcome. , 2005, Blood reviews.

[20]  C. Mullighan,et al.  Mannose‐binding lectin: biology and clinical implications , 2005, Internal medicine journal.

[21]  C. Mullighan,et al.  Mannose-binding Lectin and Infection Following Allogeneic Hemopoietic Stem Cell Transplantation , 2004, Leukemia & lymphoma.

[22]  R. Porcher,et al.  Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. , 2002, Blood.

[23]  K. Schmiegelow,et al.  Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia. , 2002, Blood.

[24]  F. Oguz,et al.  A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. , 2002, Leukemia research.

[25]  S. Thiel,et al.  Control of the classical and the MBL pathway of complement activation. , 2000, Molecular immunology.

[26]  K. Hasegawa,et al.  Characterization of human serum mannan-binding protein promoter. , 1999, Journal of biochemistry.

[27]  W. Leisenring,et al.  Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.

[28]  M. Turner,et al.  Mannose-binding lectin: the pluripotent molecule of the innate immune system. , 1996, Immunology today.

[29]  S. Thiel,et al.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. , 1995, Journal of immunology.

[30]  L. Robison,et al.  Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type , 1995, Cancer.

[31]  A. Hill,et al.  High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene , 1992 .

[32]  J. Ritter,et al.  Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group. , 1990, Blood.

[33]  Kimberly J. Johnson,et al.  Epidemiology of Acute Childhood Leukemia , 2011 .

[34]  M. Hijikata,et al.  Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL , 1998, Archives of Virology.

[35]  M. Jeannet,et al.  HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia. , 1981, Acta Haematologica.